TY - JOUR
T1 - Review on counter measures to coronavirus disease 2019 (COVID-19) pandemic, May 2020
AU - Kidaka, Taishi
AU - Lokupathirage, Sithumini M.W.
AU - Muthusinghe, Bungiriye Devinda Shameera
AU - Pongombo, Boniface Lombe
AU - Wastika, Christida
AU - Wei, Zhouxing
AU - Yoshioka, Shizuka
AU - Ishizuka, Mayumi
AU - Sakoda, Yoshihiro
AU - Kariwa, Hiroaki
AU - Isoda, Norikazu
PY - 2020/1/1
Y1 - 2020/1/1
N2 - An outbreak of novel coronavirus infection occurred in China at the end of 2019, which was designated as coronavirus disease 2019 (COVID-19), and spread to regions across Asia and ultimately all over the world. As of 21 May 2020, a total of more than 5 million cases with more than 350 thousand deaths were reported worldwide. Evaluation of the pathogenicity of the disease and determining the efficacy of control measures are essential for rapid containment of the disease. However, the world is facing difficulties in controlling COVID-19 at both of the national and global levels due to variations in pathogenicity of infection by severe acute respiratory syndrome coronavirus 2, the causal agent of COVID-19, and to diverse measures applied in each country based on their control capacities and policies. In the present review, we summarize the basic information and findings related to the COVID-19 pandemic, including pathogen agent, epidemiology, disease transmission, and clinical manifestations. Diagnosis, treatment, and preventive measures applied or under development all over the world are also reviewed to provide the opportunity to establish a more effective scenario for disease containment. Humanity has progressed by developing countless great technologies and immense scientific theories, however it may be a fact that we cannot conquer all risks to humanity. New findings and challenges for the unprecedented pandemic at the global level, such as COVID-19, should also contribute to preparedness for unknown diseases in future, similar to the lessons learnt from severe acute respiratory syndrome and the pandemic A(H1N1)pdm09 influenza.
AB - An outbreak of novel coronavirus infection occurred in China at the end of 2019, which was designated as coronavirus disease 2019 (COVID-19), and spread to regions across Asia and ultimately all over the world. As of 21 May 2020, a total of more than 5 million cases with more than 350 thousand deaths were reported worldwide. Evaluation of the pathogenicity of the disease and determining the efficacy of control measures are essential for rapid containment of the disease. However, the world is facing difficulties in controlling COVID-19 at both of the national and global levels due to variations in pathogenicity of infection by severe acute respiratory syndrome coronavirus 2, the causal agent of COVID-19, and to diverse measures applied in each country based on their control capacities and policies. In the present review, we summarize the basic information and findings related to the COVID-19 pandemic, including pathogen agent, epidemiology, disease transmission, and clinical manifestations. Diagnosis, treatment, and preventive measures applied or under development all over the world are also reviewed to provide the opportunity to establish a more effective scenario for disease containment. Humanity has progressed by developing countless great technologies and immense scientific theories, however it may be a fact that we cannot conquer all risks to humanity. New findings and challenges for the unprecedented pandemic at the global level, such as COVID-19, should also contribute to preparedness for unknown diseases in future, similar to the lessons learnt from severe acute respiratory syndrome and the pandemic A(H1N1)pdm09 influenza.
KW - COVID-19
U2 - 10.14943/jjvr.68.3.133
DO - 10.14943/jjvr.68.3.133
M3 - Article
SN - 0047-1917
VL - 68
SP - 133
EP - 150
JO - Japanese Journal of Veterinary Research
JF - Japanese Journal of Veterinary Research
IS - 3
ER -